Keystone Symposia Scientific Advisory Board

The Scientific Advisory Board (SAB) is comprised of eminent biomedical scientists whose expertise derives from academia, industry, and the government. The SAB is tasked with guiding the development of the conference portfolio, prioritizing content and topics, and providing a substantive peer review process to ensure Keystone Symposia's reputation as the preeminent convener of scientific conferences in the biomedical and life sciences.

To learn more about the functions of the SAB, please click here.

Board of Directors are denoted with a # following their name.

E. Dale Abel, M.D., Ph.D.#
Director F.O.E. Diabetes Research Center
Professor of Medicine and Biochemistry
University of Iowa, Carver College of Medicine

George Addona, Ph.D.
Executive Director
Merck Research Labs

Clement Adebamowo, B.M., Ch.B., Hons, Sc.D.
Professor Epidemiology and Public Health
Associate Director Population Science,
Greenebaum Comprehensive Cancer Center
Member, Institute of Human Virology
University of Maryland School of Medicine

Luciano Adorini, M.D.
Chief Scientific Officer
Preclinical Research
Intercept Pharmaceuticals, Inc.

Eric H. Baehrecke, Ph.D.
Department of Molecular, Cell and Cancer Biology
University of Massachusetts Medical School

Jacques F. Banchereau, Ph.D.
Professor and Director of Immunological Sciences
The Jackson Laboratory for Genomic Medicine

Dominic P. Behan, Ph.D., D.Sc.
Chief Executive Officer
Sentia Medical Sciences, Inc.

Yasmine Belkaid, Ph.D.
Director NIAID Microbiome Program
Chief Mucosal Immunology Section
Laboratory of Parasitic Disease
NIAID, National Institutes of Health

Ralph A. Bradshaw, Ph.D.#
Professor Emeritus
Department of Physiology and Biophysics
University of California, Irvine

Cherié L. Butts, Ph.D.#
Associate Director
Portfolio Leadership

Robert Califf, M.D., MACC#
Donald F. Martin, MD Professor of Cardiology
Duke University
School of Medicine

Roger D. Cone, Ph.D.
Life Sciences Institute
University of Michigan

Rodrigo Corrêa-Oliveira, Ph.D.
Vice President
Research and Biological Collections

Russell A. DeBose-Boyd, Ph.D.
Molecular Genetics
University of Texas Southwestern Medical Center

Edward A. Dennis, Ph.D.#
Chemistry, Biochemistry and Pharmacology
School of Medicine
University of California, San Diego

Vishva M. Dixit, M.D.#
Vice President, Early Discovery Research and Physiological Chemistry
Genentech, Inc.

Aris N. Economides, Ph.D.
Vice President
Regeneron Pharmaceuticals, Inc.

Martin P. Edwards, Ph.D.
Vice President
Oncology Medicinal Chemistry
Cancer Research Chemistry
Pfizer La Jolla

Markus Enzelberger, Ph.D.
Senior Vice President
Discovery, Alliances and Technologies
MorphoSys AG

Peter M. Finan, Ph.D.#
Venture Partner
Epidarex Capital

Stacey Gabriel, Ph.D.
Senior Director
Genomics Platform
The Broad Institute

Adolfo García-Sastre, Ph.D.
Department of Microbiology
Mount Sinai School of Medicine

Tariq Ghayur, Ph.D.
Senior Research Fellow
AbbVie Inc.

Geoffrey S. Ginsburg, M.D., Ph.D.
Center for Applied Genomics and Precision Medicine
Duke University

Margaret A. Goodell, Ph.D.#
Professor, Pediatrics
Director of Stem Cells & Regenerative Medicine Center
Baylor College of Medicine

Richard J. Gregory, Ph.D.
Chief Scientific Officer
Research & Development
ImmunoGen Inc.

Austin Gurney, Ph.D.
Chief Scientific Officer
Senior Vice President, Research
OncoMed Pharmaceuticals, Inc.

Curtis C. Harris, M.D.#
Chief, Laboratory of Human Carcinogenesis
NCI / National Institutes of Health

Tim Harris, Ph.D.
Executive Vice President of Research and Development
Bioverativ Therapeutics

De' Broski R. Herbert, Ph.D.
Associate Professor of Infectious Immunology
School of Veterinary Medicine
University of Pennyslvania

Linda Slanec Higgins, Ph.D.
Vice President , Biology
Gilead Sciences, Inc.

Sean Hill, Ph.D.
Director, Krembil Centre for Neuroinformatics
Center for Addiction and Mental Health
Professor, Department of Psychiatry, University of Toronto
Professor, Blue Brain Project, École Polytechnique Fédérale de Lausanne (EPFL)

Pamela M. Holland, Ph.D.
Vice President
Cancer Biology
Surface Oncology

Michael C. Holmes, Ph.D.
Vice President of Research
Sangamo Therapeutics, Inc.

Michael J. Holtzman, MD
Herman and Selma Seldin Professor of Medicine
Director, Pulmonary and Critical Care Medicine
Washington University in St. Louis

Tony Hunter, Ph.D.
American Cancer Society Professor
Renato Dulbecco Chair in Cancer Research
Salk Institute for Biological Studies

Aron B. Jaffe, Ph.D.
Senior Investigator
Group Leader, Tissue Repair & Microbiome
Chemical Biology & Therapeutics
Novartis Institute for BioMedical Research

Thale C. Jarvis, Ph.D.#
Chief Scientific Officer
Keystone Symposia

Allan R. Jones, Ph.D.
Chief Executive Officer
Allen Institute for Brain Science

Takashi Kadowaki, M.D., Ph.D.
Professor and Chairman
Graduate School of Medicine, Diabetes and Metabolic Diseases
University of Tokyo

Christopher L. Karp, M.D.
Deputy Director, Vaccines & Host-Pathogen Biology
Global Health Discovery & Translational Sciences
Bill & Melinda Gates Foundation

Karla A. Kirkegaard, Ph.D.
Violetta Horton Professor
Genetics & Microbiology & Immunology
Stanford University School of Medicine

Christian Klein, Ph.D.
Distinguished Scientist
Roche Pharmaceutical Research & Development
Roche Innovation Center Zürich

Melanie A. Kleinschek, D.V.M., Ph.D.
Senior Director, Head of Biology
Theravance Biopharma

Mark Kowala, B.Sc., Ph.D.
Chief Scientific Officer
Eli Lilly Research Lab

Martin Kussmann, Ph.D.
Professor, Systems Biology in Nutrition and Health
Liggins Institute, University of Auckland
Chief Scientist, High Value Nutrition
A New Zealand National Science Challenge

Jeffrey L. Kutok, M.D., Ph.D.
Chief Scientific Officer
Infinity Pharmaceuticals, Inc.

Tony K.T. Lam, Ph.D.
Professor and J.K. McIvor Endowed Chair in Diabetes Research
Canada Research Chair in Obesity
Associate Director, Banting and Best Diabetes Centre
Advanced Diagnostics and Metabolism
Toronto General Research Institute

Philip J. Larsen, M.D., Ph.D.
Global Head Diabetes Discovery and Early Clinical Development
R&D, Germany

Jan E. Leach, Ph.D.
University Distinguished Professor
Bioagricultural Sciences
Colorado State University

Hyam I. Levitsky, M.D.
Executive Vice President
Research & Chief Scientific Officer
Juno Therapeutics

Dangsheng Li, Ph.D.
Deputy Editor-in-Chief
Cell Research
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences

Juan Carlos Lopez, Ph.D.#
Haystack Science

Timothy B. Lowinger, Ph.D.
Chief Scientific Officer
Mersana Therapeutics

Paolo G. V. Martini, Ph.D.
Chief Scientific Officer
Rare Diseases

Lamine Mbow, Ph.D.
Executive Director
Immunology & Respiratory Disease Research
Boehringer Ingelheim

M. Juliana McElrath, M.D., Ph.D.
Senior Vice President, Director and Member
Vaccine and Infectious Disease Division
Fred Hutchinson Cancer Research Center

Elizabeth M. McNally, M.D., Ph.D.
Center for Genetic Medicine
Northwestern University Feinberg School of Medicine

Juanita L. Merchant, M.D., Ph.D.
H. Marvin Pollard Professor of Gastrointestinal Sciences
Departments of Internal Medicine and Molecular and Integrative Physiology
University of Michigan

Tara Mirzadegan, Ph.D.
Senior Director
Janssen R&D: Pharmaceutical Companies of Johnson & Johnson

Craig Monell, Ph.D.
Vice President
Business Operations/R&D
BioLegend, Inc.

Walter H. Moos, Ph.D.#
President (ret.), SRI Biosciences
Professor (adj.), University of California, San Francisco
CEO, ShangPharma Innovation

Dominik Mumberg, Ph.D.
Vice President
Oncology II
Bayer HealthCare

Leon O. Murphy, Ph.D.
Third Rock Ventures

Vic E. Myer, Ph.D.
Chief Technology Officer
Editas Medicine, Inc.

Gary J. Nabel, M.D., Ph.D.#
Chief Scientific Officer
Research and Development

Steven G. Nadler, Ph.D.
Executive Director
Translational Research Immuno-Sciences
Biology Drug Discovery
Bristol-Myers Squibb Company

Anne O'Garra, Ph.D., FRS, FMedSci#
Associate Research Director
The Francis Crick Institute
Mill Hill Laboratory

Gary Paul O'Neill, Ph.D.
Vice President, Biology and Drug Discovery
Department of Biology and Drug Discovery
Abide Therapeutics Inc.

Eric M. Parker, Ph.D.
Synergy Partners R&D Solutions

Paul W. H. I. Parren, Ph.D.
Department of Immunohematology and Blood Transfusion
Leiden University Medical Center

Jane L. Peterson, Ph.D.#
President and Chief Executive Officer
Keystone Symposia

Mark Powers, Ph.D.
Senior Director, Research and Development
Cell Biology
Thermo Fisher Scientific

Bali Pulendran, Ph.D.
Professor, Pathology and of Microbiology and Immunology
Stanford University School of Medicine

Michael H. Rabinowitz, Ph.D.
Vice President
Akebia Therapeutics, Inc

Laszlo Radvanyi, Ph.D.
Senior Vice President, Global Head of Immuno-Oncology R&D
Immuno-Oncology Translational Innovation Platform
EMD Serono / Merck KGaA, Darmstadt Germany

Ronald Raines, Ph.D.
Department of Chemistry
Massachusetts Institute of Technology

Richard M. Ransohoff, M.D.
Third Rock Ventures

Rino Rappuoli, Ph.D.
Chief Scientist and Head of External Research and Development
GlaxoSmithKline Vaccines

Bing Ren, Ph.D.
Ludwig Institute for Cancer Research

Mark Rolfe, Ph.D.
Corporate Vice President
Research & Early Development

Cristina M. Rondinone, Ph.D.
Vice President, Research and Development
Head, Cardiovascular and Metabolic Diseases
MedImmune, Inc.

Kei Sakamoto, Ph.D.
Head, Diabetes and Circadian Rhythms
Nestlé Institute of Health Sciences

Alejandro Sánchez Alvarado, Ph.D.
Stowers Institute for Medical Research/HHMI

Ali Shilatifard, Ph.D.
Robert Francis Furchgott Professor
Chairman, Department of Biochemistry and Molecular Genetics
Northwestern University Feinberg School of Medicine

Frank J. Slack, Ph.D.
Institute for RNA Medicine
BIDMC Cancer Center/Harvard Medical School

Barry P. Sleckman, M.D., Ph.D.
Vice Chair for Research
Pathology and Laboratory Medicine
Weill Cornell Medical College

Hans Ulrich Stilz, Ph.D.
Vice President
R&D Academic Partnerships
Novo Nordisk A/S

Boris Striepen, Ph.D.
Professor of Microbiology and Immunology
Department of Pathobiology
School of Veterinary Medicine
University of Pennsylvania

Lynda M. Stuart, M.D., Ph.D.
Deputy Director
Global Health, Discovery & Translational Sciences
Bill & Melinda Gates Foundation

Eric E. Swayze, Ph.D.
Vice President
Medicinal Chemistry
Ionis Pharmaceuticals, Inc.

Antony Symons, D. Phil.
Principal Scientist
Inflammation Research
Amgen Inc.

Paul K.H. Tam, ChM
Provost and Deputy Vice-Chancellor
Li Shu-Pui Professor and Chair of Pediatric Surgery
The University of Hong Kong

Cormac Taylor, Ph.D.
Professor of Cellular Physiology
University College Dublin

Fred Van Goor, Ph.D.
Principal Research Fellow
Vertex Pharmaceuticals Incorporated

Joanne L. Viney, Ph.D.
JLV Biotech Consulting

Michael J.O. Wakelam, Ph.D.
Institute Director
The Babraham Institute

Yibin Wang, Ph.D.
Anesthesiology, Physiology and Medicine
University of California, Los Angeles
David Geffen School of Medicine

Andrew B. Ward, Ph.D.
Associate Professor
Integrative Structural and Computational Biology
The Scripps Research Institute

Stephanie Wengert Watts, Ph.D.
Professor, Assistant Dean
Pharmacology & Toxicology
Michigan State University

Joseph C. Wu, M.D., Ph.D.
Professor and Director of Stanford Cardiovascular Institute
Medicine and Radiology
Stanford University School of Medicine

Tadataka Yamada, M.D.#
Managing Partner
Mountain Field LLC

Xuebiao Yao, Ph.D.
Professor and Head
Cellular Dynamics
University of Science & Technology of China

Bei B. Zhang, Ph.D.#
Vice President, Metabolic Research
Worldwide Research and Development
Internal Medicine
Pfizer Inc.

Michael J. Zigmond, Ph.D.
Professor of Neurology, Psychiatry and Behavioral and Community Health Sciences
University of Pittsburgh

plus representatives to be announced from:
Cancer Research UK
Incyte Corporation
Takeda Pharmaceutical Company Limited